Brazilian Journal of Anesthesiology
Brazilian Journal of Anesthesiology
Clinical Research

Effect of palonosetron, ondansetron and dexamethasone in the prevention of postoperative nausea and vomiting in video cholecystectomy with total venous anesthesia with propofol-remifentanil − randomized clinical trial

Efeito da palonosetrona, ondansetrona e dexametasona na prevenção de náusea e vômito pós-operatório em videocolecistectomia com anestesia venosa total com propofol-remifentanil – ensaio clínico randomizado duplo cego

Neuber Martins Fonseca, Ludmila Ribeiro Pedrosa, Natália Melo, Ricardo de Ávila Oliveira

Downloads: 0
Views: 641


Introduction and objectives
The incidence of Postoperative Nausea and Vomiting (PONV) after video cholecystectomy is high. Progress in pharmacological PONV prophylaxis includes a new generation of 5-HT3 antagonists. This study aims to assess the effect of the 5-HT3 antagonist in postanesthetic antiemetic management of patients submitted to laparoscopic cholecystectomy with total intravenous anesthesia.

Sixty individuals who underwent video cholecystectomy were randomized into three groups of 20 individuals according to the treatment administered: 0.125 mg of palonosetron (Group 1); 4 mg of ondansetron associated with 4 mg of dexamethasone (Group 2); 4 mg of dexamethasone (Group 3). General intravenous anesthesia was performed with propofol, remifentanil and rocuronium. The group to which the participant belonged was concealed from the investigator who assessed drug effect. PONV was assessed using the Rhodes Scale at 12 and 24 hours after surgery. Rescue medication was 0.655 to 1.5 mg of droperidol.

Group 1 presented a lower incidence of PONV and required less rescue medication in the first postoperative hour. There was no significant difference among the three groups regarding PONV incidence in the first 12 postoperative hours. Groups 1 and 2 were superior to Group 3 regarding the control of PONV from 12 to 24 hours, and after rescue medication from 12 to 24 hours. Group 1 showed significantly superior nausea control in the first 12 postoperative hours.

The present study showed evidence that palonosetron is superior to the drugs compared regarding a protracted antiemetic effect and less requirement of rescue drugs, mainly related to its ability to completely inhibit the uncomfortable symptom of nausea.


Anesthesia, adverse effects;  Antiemetics, therapeutic use;  Cholecystectomy, laparoscopic, adverse effects


Justificativa e objetivo
Náuseas e Vômitos (NVPO) têm alta incidência após videocolecistectomia. Avanços na profilaxia farmacológica de NVPO incluem a nova geração de antagonista 5-HT3. O objetivo deste estudo foi avaliar o efeito do antagonista 5-HT3 no controle antiemético pós-anestésico em videocolecistectomia com anestesia venosa total.

Estudo realizado no HC-UFU (Hospital terciário). Sessenta indivíduos submetidos a videocolecistectomia foram randomizados em três grupos de igual número, sendo administrados 0,125 mg de palonosetrona (Grupo 1); 4 mg de ondasetrona e 4 mg de dexametasona (Grupo 2); ou 4 mg de dexametasona (Grupo 3). A anestesia geral venosa foi realizada com propofol, remifentanil e rocurônio. O avaliador do efeito da droga desconhecia o grupo ao qual o indivíduo pertencia. NVPO foi avaliada aplicando a Escala de Rhodes após 12 e 24 horas do término da cirurgia. Para resgate terapêutico, foi estabelecido 0,655–1,5 mg de droperidol.

Observou-se no Grupo 1 menor incidência de NVPO e de resgate terapêutico na primeira hora de PO. Não foi observada diferença significativa entre os três grupos com relação a ocorrência de NVPO nas primeiras 12 horas de pós-operatório. Os grupos 1 e 2 foram superiores ao Grupo 3 no que se refere ao controle de NVPO de 12 a 24 horas e após o resgate de 12–24 horas. Observou-se que o controle de náuseas nas primeiras 12 horas de pós-operatório do Grupo 1 foi significantemente superior.

O presente estudo mostrou evidências da superioridade da palonosetrona às demais drogas empregadas no que se refere ao efeito antiemético prolongado e menor necessidade de resgate, principalmente na capacidade de inibir completamente o desconfortável sintoma de náusea.


Anestesia, efeitos adversos;  Antiémeticos, uso terapêutico;  Colecistectomia laparoscópica, efeitos adversos


1 P.A. Kapur The big “little problem” Anesth Analg., 73 (1991), pp. 243-245

2 M.S. Sniadach, M.S. Alberts A comparison of the prophylactic antiemetic effect of ondansetron and droperidol on patients undergoing gynaecologic laparoscopy Anesth Analg., 85 (1997), pp. 797-800

3 C.C. Apfel, E. Laara, M. Koivuranta, et al. A simplified risk scores for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centres Anesthesiology., 91 (1999), pp. 693-700

4 T.J. Gan, K.G. Belani, S. Bergese, et al. Foruth consensus guidelines for the management of postoperative nausea and vomiting Anesth Analg., 131 (2020), pp. 411-448

5 D.L. Paxton, C.A. Mckay, K.R. Mirakin Prevention of nausea and vomiting after day case gynaecological laparoscopy. A comparison of ondansetron, droperidol, metoclopramide and placebo Anaesthesia., 50 (1995), pp. 403-406

6 P.S. Loewen, C.A. Marra, P.J. Zed 5-HT3 receptor antagonists vs. traditional agents for the prophylaxis of postoperative nausea and vomiting Can J Anaesth., 47 (2000), pp. 1008-1018

7 E.H. Wong, R. Clark, E. Leung, et al. In vitro the interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors Br J Pharmacol., 114 (1995), pp. 851-859

8 R. Core, R. Team A language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria (2013)

9 W.J. Conover Practical nonparametric statistics (3. ed.), John Wiley & Sons, Inc (1999)

10 O.J. Dunn Multiple comparisons using rank sums Technometrics., 6 (1964), pp. 241-252

11 D.J. Rowbotham Current management of postoperative nausea and vomiting Br J Anaesth., 69 (1992), pp. 46-59

12 H.D. Boer, O. Detriche, P. Forget Opiod-related side effects: postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature Best Pract Res Clin Anaesthesiol., 31 (2017), pp. 499-504

13 G.W. Roberts, T.B. Bekker, H.H. Carlsen, et al. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose related manner Anesth Analg., 101 (2005), pp. 1343-1348

14 D.R. Sinclair, F. Chung, G. Mezei Can postoperative nausea and vomiting be predicted? Anesthesiology., 91 (1999), pp. 109-118

15 C.C. Apfel, P. Kranke, M.H. Katz, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design Br J Anaesth., 88 (2002), pp. 659-668

16 C.C. Apfel, P. Kranke, L.H. Eberhart Comparison of surgical site and patient’s history with a simplified risk score for the prediction of postoperative nausea and vomiting Anaesthesia., 59 (2004), pp. 1078-1082

17 M.M. Cohen, P.G. Duncan, D.P. DeBoer, et al. The postoperative interview: assessing risk factors for nausea and vomiting Anesth Analg., 78 (1994), pp. 7-16

18 J. Wallenborn, G. Gelbrich, D. Bulst, et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double-blind multicentre trial BMJ., 333 (2006), p. 324

19 A.S. Habib, T.J. Gan Evidence-based management of postoperative nausea and vomiting: a review Can J Anaesth., 51 (2004), pp. 326-341

20 N.H. Waldron, C.A. Jones, T.J. Gan, et al. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis BJA., 110 (2013), pp. 191-200

21 C. Rojas, M. Stathis, A.G. Thomas, et al. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor Anesth Analg., 107 (2008), pp. 469-478

22 C. Rojas, Y. Li, J. Zhang, et al. Anti- emetic 5-HT3 receptor antagonist palonosetron inhibits substance P-mediated responses in vitro and in vivo J Pharmacol Exp Ther., 335 (2010), pp. 362-368

23 S.K. Park, E.J. Cho A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery J Int Med Res., 39 (2011), pp. 399-407

24 Y.E. Moon, J. Joo, J.E. Kim, et al. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study Br J Anaesth., 108 (2012), pp. 417-422

25 E.L.C. Braga, N.V. Figueiredo, L. Barrucand, et al. Use of palonosetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in women 60 years of age or older undergoing laparoscopic cholecystectomy: A randomized double-blind study Eur J Anaesthesiol., 36 (2019), pp. 241-242

26 A. Chatterjee, S. Sahu, M. Paul, et al. Comparison of efficacy of palonosetron- dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy Indian J Anaesth., 61 (2017), pp. 978-984

27 A. Kumar, S.L. Solanki, G.R. Gangakhedkar, et al. Comparison of palonosetron and dexamethasone with ondansetron and dexamethasone for postoperative nausea and vomiting in post-chemotherapy ovarian cancer surgeries requiring opioid-based patient- controlled analgesia: A randomised, double-blind, active controlled study Indian J Anaesth., 62 (2018), pp. 773-779

28 G.O. Campos, M.J. Martins, G.N. Jesus, et al. Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial BMC Anesthesiol., 19 (2019), pp. 2-6

29 N.G.A. Ferreira, I.L. Cavalcanti, A.R. Assad, et al. A prospective, randomized, double- blind trial to compare body weight-adjusted and fixed doses of palonosetron for preventing postoperative nausea and vomiting in obese female patients PLOS ONE., 14 (2020), pp. 1-11

5f6a618d0e882502299fefc6 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections